Search Results - "Casabal, Florencia Garcia"

Brief Research Report: Anti-SARS-CoV-2 Immunity in Long Lasting Responders to Cancer Immunotherapy Through mRNA-Based COVID-19 Vaccination by Sisteré-Oró, Marta, Wortmann, Diana D. J., Andrade, Naína, Aguilar, Andres, Mayo de las Casas, Clara, Casabal, Florencia Garcia, Torres, Susana, Bona Salinas, Eduardo, Raventos Soler, Laura, Arcas, Andrea, Esparre, Carlos, Garcia, Beatriz, Valarezo, Joselyn, Rosell, Rafael, Güerri-Fernandez, Roberto, Gonzalez-Cao, Maria, Meyerhans, Andreas

“…Cancer patients (CPs) have been identified as particularly vulnerable to SARS-CoV-2 infection, and therefore are a priority group for receiving COVID-19…”
Get full text

Fluorescence In Situ Hybridization (FISH) for the Characterization and Monitoring of Primary Cultures from Human Tumors by Román-Lladó, Ruth, Aguado, Cristina, Jordana-Ariza, Núria, Roca-Arias, Jaume, Rodríguez, Sonia, Aldeguer, Erika, Garzón-Ibañez, Mónica, García-Peláez, Beatriz, Vives-Usano, Marta, Giménez-Capitán, Ana, Aguilar, Andrés, Martinez-Bueno, Alejandro, Cao, María Gonzalez, García-Casabal, Florencia, Viteri, Santiago, Mayo de las Casas, Clara, Rosell, Rafael, Molina-Vila, Miguel Angel

“…Genetic and drug sensitivity assays on primary cultures are not only of basic but also of translational interest and could eventually aid oncologists in the…”
Get full text

Abstract 290: Comparison of clinically relevant fusions detection using two multiplexing RNA based platforms: nCounter and GeneReader by Ibañez, Mónica Garzón, Gimenez-Capitán, Ana, Usano, Marta Vives, Lladó, Ruth Román, Rodriguez, Sonia, Aldeguer, Erika, Pelaez, Beatriz García, Ariza, Nuria Jordana, Aguado, Cristina, Viteri, Santiago, Aguilar, Andrés, Moya, Irene, Cabrera, Carlos, Catalán, Maria Jose, cao, Maria Gonzalez, Garcia-Roman, Silvia, Alamillo, Jordi Bertran, Casabal, Florencia Garcia, Rosell, Rafael, Molina-Vila, Miguel Angel, De Las Casas, Clara De La Caridad Mayo

“…Background: Fusions involving the tyrosine kinase receptor genes ALK, ROS1, RET, NTRK or MET exon 14 skipping variant (METex14) are present in a significant…”
Get full text

Abstract 1610: Primary cultures from malignant pleural effusions and ascites for drug screening in personalized therapy by Aguado, Cristina A., Garcia, Beatriz, Aguilar-Hernández, Andrés, Martínez-Bueno, Alejandro, Vives-Usano, Marta, Garcia-Casabal, Florencia, Román, Ruth, Meshoulam, Ekaterina, Aldeguer, Erika, Jordana-Ariza, Nuria, García-Mosquera, Juan José, Cabrera, Carlos, Viteri, Santiago, Rodríguez, Sonia, Berrocal-Gómez, Laura, Rubinstein, Pablo, Mayo-de-las-Casas, Clara, Rosell, Rafael, Molina-Vila, Miguel Ángel

“…Background: A significant percentage of patients (p.) with solid tumors present with pleural effusion or ascitic fluid during disease history. Although…”
Get full text